Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

An Open-label, Randomized, Single Dose, 6-Sequence, 3-Period, Cross-over Study to Evaluate a Drug Interaction Between Fixed-dose Combination of Fimasartan/Amlodipine and Hydrochlorothiazide in Healthy Male Subjects

The purpose of this study is to evaluate the Drug interaction and safety of Fimasartan/Amlodipine and Hydrochlorothiazide in Healthy Male volunteers.

Inclusion Criteria:

• A healthy Male adults aged 19-50 years

Exclusion Criteria:

• History or presence of clinically significant medical or psychiatric condition or disease.
• Hypersensitivity to ingredient of IP and other medication, food.
• Participation in any other study within 3months.
• History of whole blood donation within 2months and Apheresis 1month.